The 400 m walk test has been used in older adults; however, the applicability in middle-aged populations is unknown. Methods: Data were obtained from the Evaluation of Physical Activity Measures in Middle-Aged Women (PAW) Study and included 66 women (52.6 ± 5.4 years). Participants were instructed to walk at a brisk, maintainable pace; time taken to complete the 400 m was recorded in seconds. Intraclass correlation coefficients (ICC) were used to assess test-retest reliability. Spearman rank order correlation coefficients were used to examine the concurrent validity of the walk test with cardiorespiratory fitness and associations with physical activity, body composition, flexibility, static balance, and muscular fitness, adjusted for age and body mass index. Results: Participants completed the walk at visits 4 and 5 in 248.0 and 245.0 seconds, respectively. The walk test had excellent reproducibility [ICC = 0.95 (95% CI: 0.92, 0.97)] and was significantly associated with estimated (ρ = -0.43; P < 0.0001) and measured (ρ = -0.56; P < 0.001) VO 2 max. The walk test was also significantly related to physical activity, body composition, flexibility, and balance. Conclusions: These findings support the utility of the 400 m walk test to estimate cardiorespiratory fitness and reflect free-living physical activity in healthy, middle-aged women.
More than half of sudden deaths attributable to cardiovascular disease (CVD) occur in women with no previous symptoms; 1,2 therefore, identifying asymptomatic women who are at increased risk has major public health implications. Exercise capacity is an independent predictor of cardiovascular events and death in women. [2] [3] [4] [5] Exercise capacity is defined as the maximal oxygen uptake (VO 2 max) at a given workload 4, 6 and is often estimated using a symptom-limited maximal exercise stress test. In settings where VO 2 max protocols may not be feasible to conduct, 7 self-paced walking tests have been used to estimate VO 2 max. Distance-based tests of walking endurance, including the long distance corridor walk (LDCW), evolved from timed protocols (ie, 6-minute walk) based on the premise that individuals may be more intrinsically motivated to complete a predetermined distance in as little time as possible, thus, performing closer to maximal capacity. 8, 9 The LDCW protocol, which consists of a 2-minute warm up walk followed immediately by a 400 m walk to be done at a brisk and maintainable pace, has been primarily used in well-functioning older adults to estimate cardiorespiratory fitness, 8, 9 functional status, 10 and general health; 11, 12 however, there is limited knowledge regarding the applicability of this protocol in middle-aged populations.
There is a need to examine the accuracy of simple measures that could be used in a variety of settings to help identify clinically asymptomatic women at higher CVD risk. The relationship between physical fitness and physical activity is well established. Physical fitness refers to a set of physiological attributes that can be enhanced through participation in physical activity. 13 Since walking involves the interplay of physical fitness parameters, one would expect that time to complete the 400 m walk would be related to physical activity and most physical fitness parameters. Therefore, the purposes of this investigation are to evaluate the test-retest reliability and concurrent validity of the 400 m walk test and its associations with physical activity, body composition, flexibility, static balance, and lower extremity muscular fitness in women age 45 to 65 years.
Methods
The Evaluation of Physical Activity Measures in Middle-Aged Women (PAW) Study was designed to evaluate the psychometric properties of 6 measures (ie, 5 questionnaires and a walking based performance measure) used in epidemiological studies of physical activity and health. The protocol used in the PAW Study has been previously reported.
14 Briefly, women age 45 to 65 years who were able to walk at least 1 block without the use of an assistive device, were willing to wear 2 activity monitors every day for the entire study duration, and were free of chronic or acute conditions were recruited from the Greater Phoenix metropolitan area. None of the PAW Study participants met safety related exclusion criteria for the 400 m walk test including elevated blood pressure (≥200/100 mmHg) or resting HR [>110 or <40 beats per minute (bpm)] and all women completed the walk without incident. All participants provided written informed consent, and the study protocol was approved by the institutional review board at Arizona State University. Participants completed 6 consecutive weekly visits, each lasting 30 to 60 minutes.
Seventy-seven women were screened, and 66 (85.7%) were enrolled into the study. At the initial visit, participants completed demographic and health history questionnaires; clinical and anthropometric measurements were taken by trained study staff. Using this information, study staff classified participants as moderate or low CVD risk using American College of Sports Medicine (ACSM) and American Heart Association (AHA) criteria. 15 Among the 66 women enrolled in the study, 39 (59%) were classified as moderate risk for CVD and the remaining 27 (41%) were low risk.
Meter Walk Test
The 400 m (m) walk test is a component of the LDCW that utilizes a 400 m course consisting of 10 laps along a hallway (40 m per lap) with cones set 20 m apart. Participants were instructed to walk at a brisk pace that they could maintain for the full 10 laps and heart rate (HR) was recorded using a heart rate monitor (Model FS1; Woodbury, NY). Before the walk, the participant's resting heart rate and blood pressure was measured and recorded to determine if they should be excluded from the 400 m walk test for safety reasons. Further, the walk was stopped if the participant reported any chest pain or dyspnea during the test. At the end of lap 4, while continuing to walk, participants were asked to rate their perceived exertion on a modified scale from 1 to 4. HR was recorded in the seated position before the walk, standing at test completion, and after 2 minutes of recovery. Systolic blood pressure was measured while seated, before the walk and at test completion. The 400 m walk test protocol took approximately 8 to 10 minutes to administer and was collected at visits 4 and 5.
Objective Measures of Physical Fitness
The PAW Study protocol incorporated measures representing all 5 domains of physical fitness. At visit 2, all women completed a single-stage submaximal treadmill walking test using the Ebbeling et al 16 17 VO 2 max values were excluded from the analyses if the participant reported blood pressure medication use, which can affect heart rate response (estimated VO 2 max: n = 10; measured VO 2 max: n = 1) or if they completed the maximal treadmill test but did not meet ACSM criteria 15, 18 for achievement of VO 2 max (n = 4). Body height and weight were measured with a stadiometer and calibrated balance beam scale, respectively, and body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared (kg/m 2 ). Waist circumference was measured in the standing position midway between the 10th intercostal and iliac crest using a fiberglass retractable tape measure. Percent body fat was estimated using bioelectrical impedance [Tanita Body Composition Analyzer: TBF-300A (Arlington Heights, IL)]. Lower back and hamstring flexibility was measured using the YMCA sit-and-reach test protocol, 19 lower extremity performance (ie, includes static balance, gait speed, and timed chair stands) was assessed using the SPPB, 20 and static balance was measured with the FICSIT-4. 21 Quadricep and hamstring muscle strength and endurance was measured bilaterally using an isokinetic dynamometer [HUMAC NORM (Computer Sports Medicine, Inc.; Stoughton, MA)]. Muscular strength was assessed at 60 degrees per second (°/sec), and endurance was obtained using the fatigue index score at 240°/sec, expressed as peak power minus minimum power, divided by the time interval in seconds between peak power and minimum power.
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Physical Activity: Subjective Measures
Modifiable Activity Questionnaire. The MAQ assesses leisure physical activities over the past month and past week. Physical activity levels are calculated as the product of the duration and frequency of each activity (in hours per week), weighted by an estimate of the metabolic equivalent (MET) of that activity, 23 and summed for all activities performed. Data are expressed as MET hours per week (MET·h/wk) 24 (Table 2) .
Nurses' Health Study Physical Activity Questionnaire.
The NHS PAQ, a past-week recall, included information on 10 moderate and vigorous leisure time physical activities, usual walking pace, number of flights of stairs climbed daily, and 4 sedentary activities. Physical activity levels are calculated as the product of the duration and frequency of each activity (in h/wk), weighted by an estimate of the MET of the activity, 23 and summed to give a total activity score in MET·h/wk. 25 Active Australia Survey. The Active Australia survey measures leisure physical activities over the past week, as well as sitting time during a usual week and weekend day. Physical activity levels are calculated as the duration of leisure physical activities over the past week (min/wk).
26,27
Women's Health Initiative Physical Activity Questionnaire. The WHI PAQ measures the frequency and duration of 4 walking speeds and 3 types of activity classified by intensity over the past week. Physical activity levels are calculated as the product of the duration and frequency of each activity level (in hr/wk), weighted by a standard estimate of the MET level for each activity intensity level, and summed across walking and all intensity levels.
28,29
Physical Activity: Objective Measures
The objective physical activity measures used in the PAW Study included the ActiGraph GT1M accelerometer (Pensacola, FL) and the Yamax Digiwalker SW-200 pedometer (Yamax USA: San Antonio, TX). Technical specifications, as well as reliability and validity, of the ActiGraph 30, 31 and Digiwalker 32 have been described previously. Participants wore the ActiGraph and Digiwalker everyday and were asked to record in a physical activity diary provided by study staff the times at which they put on the monitors in the morning and took them off at night, and the total number of accumulated steps (pedometer only). Participants were instructed to reset the pedometer to 0 every morning. Weekly, participants exchanged a completed diary for a new one to be completed during the following week. The number of pedometer steps recorded in the physical activity diary each week was averaged to obtain a 7-day daily average. Data from the accelerometer were downloaded and processed weekly and were screened for wear time using previously reported methods consistent with publicly available SAS code developed to process the 2003 to 2004 NHANES accelerometerdetermined physical activity data. 33 Average total activity counts per day were calculated using summed daily counts detected over wear periods and were compared with the PAQ summary estimate as a measure of total physical activity. Time spent in moderate (1952 to 5724 cts/min) and vigorous (≥5725 cts/min) intensity physical activity was estimated using Freedson 34 cut-points for each day with ≥ 10 hours of wear time. A moderate to vigorous physical activity (MVPA) category was computed with a threshold of ≥1952 cts/min. 30, 34 Weekly summary estimates were compiled for all participants with at least 4 valid days of accelerometer data (98.5% of study participants).
Statistical Methods
Univariate analyses were conducted on 400 m walk test parameters, demographics, anthropometric measures, and physical activity and physical fitness levels. All variables were assessed for normality. Normally distributed variables were reported as mean and standard deviation and nonnormally distributed variables as medians with 25th and 75th percentiles; proportions were noted for categorical variables. The test-retest reliability of the time taken to complete the 400 m walk was assessed using intraclass correlation coefficients (ICC). The strength of agreement for the ICC ranges was interpreted as follows: <0.00, poor; 0.00 to 0.20, slight; 0.21 to 0.40, fair; 0.41 to 0.60, moderate; 0.61 to 0.80, substantial; and 0.81 to 1.00, almost perfect. 35 The concurrent validity of the 400 m walk test with cardiorespiratory fitness and the associations between total walk time and subjective and objective measures of physical activity, body composition, flexibility, static balance, and lower extremity muscular fitness were examined using Spearman rank order correlation coefficients. Partial correlations were used to further explore whether the results warranted after additional adjustment by age and BMI, as these factors have been shown to be associated with gait speed. 36, 37 ICCs were estimated using SPSS 16.0 (Chicago, Illinois), and all remaining statistical analyses were conducted using SAS 9.2 (Cary, North Carolina).
Results
Descriptive Statistics
The characteristics of the study participants are presented in Table 1 seconds, respectively. Reported physical activity (via PAQs) and pedometer data suggest that participants met current recommendations for physical activity; 38 however, accelerometer-determined MVPA did not confirm these findings. The results obtained from the battery of physical fitness measures suggest that, on the whole, PAW Study participants had below average to average fitness levels ( Table 1) .
Reliability and Validity
The test-retest ICC with 95% confidence intervals for the time taken to complete the 400 m walk is shown in Figure 1 . The 1-week test-retest reliability of walk time from the 400 m walk was 0.95 [(95% CI: 0.92, 0.97) P < .0001)], suggesting excellent reproducibility (Figure 1) .
m Walk Time vs. Physical Activity Measures
All PAQs were associated with time taken to complete the 400 m course at visit 5 [-0.30 to -0.40 (all P < 0.05)], with the strongest relationship observed with the past week MAQ. Total time taken to complete the 400 m was significantly related to accelerometer-determined data [-0.37 to -0.55 (all P < 0.01)], with the strongest association observed with vigorous-intensity physical activity, and was significantly correlated with average daily pedometer steps [-0.51 (all P ≤ .0001)]. After adjustment for age and BMI, the relationship between time taken to complete the 400 m course and physical activity measures slightly attenuated but remained statistically significant (Table 2) .
m Walk Time vs. Physical Fitness Measures
For the unadjusted associations, time taken to complete the 400 m was significantly related to measured (-0.66, P < .001) and estimated VO 2 max (-0.60, P < .0001)]. Time taken to complete the 400 m course was directly related to percent body fat and waist circumference (0.63 and 0.62, respectively; both P < .0001) and was inversely associated with flexibility (-0.32, P < .01), lower leg performance using the SPPB (-0.36, P < 0.01), and static balance from the FICSIT-4 (-0.34, P < 0.01). Time taken to complete the 400 m was not associated with muscle strength or endurance of either the right or left extremity.
After adjustment for age and BMI, the relationships between time taken to complete the 400 m and physical activity and physical fitness measures did not differ. Yet, total time was no longer significantly associated with the Active Australia survey, lower leg performance (SPPB), or muscular fitness (Table 2) .
Discussion
To our knowledge, no previous study has evaluated the psychometric properties of the 400 m walk test in healthy, middle-aged women against a comprehensive set of physical activity and physical fitness measures. All PAW Study participants successfully completed both the initial test and retest of the 400 m walk test, which confirms previous work in postmenopausal women 39 that found the protocol to be a tolerable measure in this population. Furthermore, all participants completed the protocol without stopping due to chest pain, shortness of breath, or any other exercise-related symptoms.
The average self-selected walking speed used to complete the course was approximately 3.6 mph during the first administration of the 400 m walk test and 3.7 mph during the retest; speeds that are both considered "brisk" and confirm compliance to the verbal instructions given before the protocol. The average walking speed observed in the PAW Study was faster than that reported in the Women On the Move through Activity and Nutrition (WOMAN) Study 39 (301.2 seconds; 1.3 m/sec or 2.9 mph). The difference in self-selected walking pace may be due to the fact that WOMAN Study participants were slightly older (57.0 ± 2.9 vs. 52.6 ± 5.4 years) and had a higher average BMI (30.8 ± 3.8 vs. 26.8 ± 5.1 kg/m 2 ) 39 than PAW Study participants. In the Health, Aging and Body Composition (Health ABC) study, well-functioning older adults took even longer to complete the 400 m course (323 seconds; 1.2 m/sec or 2.7 mph). 11, 12 Together, these findings support the potential effect of age and body size/weight on walking performance. 36, 37 The 400 m walk test was shown to be highly reproducible in middle-aged women. The test-retest correlation observed in the current study found a 95% consistency in walking performance from one week to the next, which suggests that the 400 m walk test is not subject to technical sources of variability. Assessing the reliability of an instrument is particularly critical when evaluating the overall quality of a measure, because without instrument reliability, there can be no validity.
The concurrent validity of the 400 m walk test to provide an estimate of cardiorespiratory fitness was demonstrated with the favorable comparisons that were observed with VO 2 max. Lacking physician oversight, we were unable to measure VO 2 max in more than half of the PAW Study participants, who were classified as moderate CVD risk. 19 Furthermore, women 55 years or older were systematically classified as moderate risk; therefore, the concurrent validity of the 400 m walk test was not evaluated in these women. Finally, the necessity of wearing equipment (ie, nonrebreathing valve attached to head gear or mask) and walking on a treadmill during the maximal graded exercise test could have compromised maximal performance by inducing test anxiety, which may have caused some participants to prematurely meet ACSM criteria for test termination. 15, 18 Regardless, the observed a Adjusted for age only. † P < .10; *P < .05; **P < .01; ***P < .001; ****P < .0001.
associations between total time taken to complete the 400 m course and VO 2 max were strong enough to reach statistical significance, even after adjustment for age and BMI. Post hoc power analyses revealed that the power to examine the relationship between the walk time and measured and estimated VO 2 max, after adjustment for age and BMI, was 81% and 92%, respectively. Total walk time was significantly related to physical activity, percent body fat, flexibility, and static balance. In the WOMAN Study, time taken to complete the 400 m walk test was shown to be inversely related to the past year MAQ and pedometer steps. 39 Similarly, walk time was inversely related to self-reported physical activity levels in the Health ABC study. 12 To our knowledge, the current study is the first to examine the relationship between the 400 m walk test and accelerometer-determined data. Given that lean mass is the major site of oxygen uptake during exercise, the longer walk times that were found in participants with higher fat mass and larger waist circumference were not unexpected, and similar findings were documented in previous studies. 12, 40 The relationships between the 400 m walk test and flexibility and static balance are novel, but not surprising, since walking involves both flexibility and balance. Surprisingly, time taken to complete the 400 m walk test was not related to quadriceps and hamstring muscular fitness. Perhaps muscular fitness is not as critical to walking performance as aerobic capacity. It has also been hypothesized that the contribution of muscular strength to walking performance is not linear and that poor strength will only negatively affect walking if it falls below a certain threshold. 41 There are several limitations to consider when interpreting the results of the current investigation. The study population consisted of a convenience sample of mostly educated, non-Hispanic white women, with no reported comorbidities, which may limit the generalizabililty of the findings to more diverse populations. Total time taken to complete the 400 m could have been hindered if the participant had to slow down or take a wider step to navigate around the cones that were placed at opposite sides of the corridor. However, each participant was given a visual demonstration of 1 complete lap, including specific instructions on how to efficiently turn around the cones. In addition, walking performance could have been influenced by individual-level differences in the interpretation of the instructions provided before the test and by motivation to complete the 400 m course at a "brisk but maintainable" pace. It is difficult to determine the degree to which interpretive or motivational differences affected overall walking performance. Finally, in addition to evaluating 400 m walk test against a comprehensive set of objective physical fitness and physical activity measures, walk time was also compared with physical activity questionnaires that are commonly used among middle-aged women; it is important to note that subjective questionnaires are often subject to recall bias. 42 CVD continues to be the leading cause of death among women in the United States, 43 with a large proportion of deaths occurring in women with no previous symptoms.
1,2 Therefore, the identification of effective strategies to assess women based on CVD risk is vital to prevention efforts. 44 The findings from the current study support the utility of the 400 m walk test to estimate exercise capacity in apparently healthy, middle-aged women. This information could potentially be used by health care providers to supplement traditional CVD risk assessment strategies, prioritize individuals for follow-up screening or intensive intervention, or evaluate progress in lifestyle-based programs.
